SoftFil® Micro-Cannula Technology

Controlled Delivery, Reduced Trauma, and Improved Outcomes

SoftFil® is a specialised micro-cannula injection system designed to optimise the delivery of dermal fillers and injectable treatments. Now part of Prollenium Medical Technologies, the brand represents a critical evolution in how aesthetic treatments are performed, focusing on controlled delivery, reduced tissue trauma, and improved procedural outcomes.

Originally developed by aesthetic physician Dr Sandrine Sebban, SoftFil® introduced micro-cannula techniques to modern aesthetic medicine, helping shift the industry toward safer, more refined injection protocols.

The Science of Micro-Cannula Technology

Prollenium’s integration of SoftFil® reflects a clear clinical objective: to improve not just what is injected, but how it is delivered.

While hyaluronic acid fillers have evolved significantly, treatment outcomes still depend heavily on injection technique, depth accuracy, and tissue interaction. SoftFil® addresses these variables by providing engineered delivery systems that enhance control and consistency, helping practitioners achieve predictable, natural-looking results. It is built on a fundamental shift away from traditional sharp needles toward blunt-tip cannula systems that interact differently with tissue. The result is a more uniform, natural aesthetic.

Controlled Tissue Navigation: SoftFil® micro-cannulas are designed to glide along natural tissue planes rather than cut through them, allowing for smoother insertion, reduced tissue disruption, and greater control in delicate areas.

Precision Placement Mechanisms: Built-in precision features—including depth markings, side-port delivery, and orientation indicators—support accurate, consistent product placement across all treatment zones.

Optimised Product Distribution: By enabling fewer entry points with broader coverage, SoftFil® also promotes even filler distribution, lower tissue pressure, and more seamless integration, resulting in refined, natural-looking outcomes.

The Smart Needle For Optimised Cannula Injection

SoftFil® EasyGuide is a patented half-needle introducer which guides SoftFil® cannulas into the dermis in one smooth action.

Simplied technique: An entry point and micro-cannula insertion in one single movement.
Precision tool: Its half-needle-shaped gutter guides the micro-cannula’s insertion to the appropriate injection level.
Ergonomic design: Ensures stability during micro-cannula insertion.

What Sets SoftFil® Apart

SoftFil® approaches injection as a science of delivery, not simply a device. Each cannula is purpose-built for aesthetic procedures, supporting advanced, multi-layered techniques and allowing practitioners to work with precision across different tissue depths. This focus on design and functionality gives practitioners greater control during treatment, helping to achieve more refined and consistent results.

Designed for Clinical Versatility: SoftFil® offers a wide range of cannula sizes and configurations, making it easy to tailor treatments based on the area, product, and depth required. This adaptability allows practitioners to confidently treat both the face and body, supporting a broad range of aesthetic indications with a customised approach.

Trusted Quality & Manufacturing Standards: Every SoftFil® device is sterile, single-use, and manufactured to strict medical-grade ISO standards. Designed specifically for trained medical professionals, these devices ensure reliable performance and consistency across all clinical environments.

Pioneering Safe and Effective Solutions for Practitioners

SoftFil® is dedicated to equipping aesthetic professionals with innovative tools that enhance precision, safety, and patient comfort. The brand offers a diverse range of high-performance products designed to optimise aesthetic procedures:

SoftFil® and Prollenium: A Powerful Partnership

In May 2022, SoftFil® joined the Prollenium Medical Technologies Inc. family, complementing Prollenium’s portfolio, which includes the renowned Revanesse® dermal filler range. This acquisition solidified a shared mission to enhance the safety and efficacy of aesthetic medicine procedures.

Ario Koshbin, founder and CEO of Prollenium, described the acquisition as a “natural fit,” aligning two brands dedicated to advancing the field of aesthetic medicine. The synergy between SoftFil®’s medical devices and Revanesse® dermal fillers provides practitioners with cutting-edge tools that optimise patient outcomes.